炎症疾病管理中的新兴范式:探索生物活性化合物和肠道微生物群
Tarek Benameur1, Chiara Porro2, Mohammed-Elfatih Twfieg1
1Department of Biomedical Sciences, College of Medicine, King Faisal University, Al-Ahsa 31982, Saudi Arabia.
Brain sciences
|August 26, 2023
概括
天然生物活性化合物 (BCs) 提供抗炎功效,调节免疫反应并保护人类健康. 这些化合物支持肠道微生物群的健康,为治疗慢性炎症疾病提供了一个有希望的途径.
科学领域:
- 微生物学和免疫学
- 营养科学 营养科学
- 药理学 药理学是指药理学的学科.
背景情况:
- 人的肠道微生物群是一个复杂的生态系统,对宿主健康至关重要,影响免疫调节,新陈代谢和病原体防御.
- 炎症是一种关键的免疫反应,与许多疾病有关,目前的治疗方法往往不足.
- 来自自然来源的生物活性化合物 (BC) 具有多种健康益处,包括显著的抗炎性质.
研究的目的:
- 审查自然生物活性化合物在调节炎症中的作用.
- 探索BCs如何通过影响炎症途径来保护人类健康.
- 评估BCs在保护肠道微生物群和改善其功能方面的安全性.
主要方法:
- 关于生物活性化合物和炎症的科学研究的文献综述.
- 分析关于BCs在炎症过程中的作用机制的研究.
- 评估有关BCs对肠道微生物群组成和功能影响的数据.
主要成果:
- 抗菌素表现出抗氧化,抗微生物和抗炎活性.
- BCs可以抑制或调节炎症介质,减少组织损伤.
- 自然BCs在治疗慢性炎症和支持肠道健康方面显示出潜力.
结论:
- 天然生物活性化合物代表了管理炎症和相关疾病的有前途的治疗策略.
- BCs可以积极影响肠道微生物群,有助于人类整体健康.
- 对BCs进行进一步的研究是有必要的,以确保其在疾病预防和治疗中的安全和有效应用.
相关概念视频
Inflammatory Bowel Disease IV: Pharmacological Management
152
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
152
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
355
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
355
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
173
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
173
Inflammatory Response
2.1K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
2.1K
Irritable Bowel Syndrome I: Introduction
313
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
313
Chronic Bowel Disorders: Introduction
485
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
485


